Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
MELBOURNE, Australia, Jan. 05, 2024 (GLOBE NEWSWIRE) — Genetic Technologies Limited (NASDAQ: GENE, “Company”) a global leader in genomics-based tests […]
WiMi Announced Image-Fused Point Cloud Semantic Segmentation with Fusion Graph Convolutional Network
Beijing, Jan. 05, 2024 (GLOBE NEWSWIRE) — WiMi Hologram Cloud Inc. (NASDAQ: WIMI) (“WiMi” or the “Company”), a leading global […]
Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
Lifecore enters into commercial agreements with Alcon that include new 8-year commercial manufacturing arrangements Lifecore receives amendment and waiver for […]
Silicon Motion Announces Preliminary Fourth Quarter 2023 Revenue and Earnings Conference Call Details
TAIPEI, Taiwan and MILPITAS, Calif., Jan. 05, 2024 (GLOBE NEWSWIRE) — Silicon Motion Technology Corporation (NasdaqGS: SIMO) (“Silicon Motion” or […]
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif., Jan. 05, 2024 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel […]
DZS Secures $25 Million in Funding and Signs Definitive Agreement to Divest Asia Business
DALLAS, Jan. 05, 2024 (GLOBE NEWSWIRE) — DZS (Nasdaq: DZSI), a global leader of access, optical and AI-driven cloud software […]
CervoMed to Participate in the Emerging Growth Conference 66
BOSTON, Jan. 05, 2024 (GLOBE NEWSWIRE) — CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for […]
Praxis Precision Medicines Announces Licensing and Collaboration Agreement with Tenacia Biotechnology for Ulixacaltamide in Greater China
Collaboration leverages Tenacia’s expertise in central nervous system drug development and commercialization and will address a significant unmet patient need […]
Augmedix Exits Calendar 2023 with Expected $51 Million in Annual Recurring Revenue
SAN FRANCISCO, Jan. 05, 2024 (GLOBE NEWSWIRE) — Augmedix, Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical […]
Compass Therapeutics Provides Corporate Update
We continue to open clinical sites and enroll patients in COMPANION-002, the Phase 2/3 randomized study of CTX-009 (DLL4 x […]
